POSTGRADUATE MEDICAL JOURNAL-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2178642, encodeId=f00221e864287, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：消化;内镜 经验分享：2023年9月投稿，一直在等待分配审稿人，11月收到邮件要求作者推荐审稿人，回复邮件后1个月状态变成了Awaiting reviewer，过了1-2周后状态变成Awaiting AE recommendation，又过了几天变成Awaiting EIC decision，等了1天，2024-01-01直接接收，审稿人提了几个意见，但没要求修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4572634636, createdName=154528445, createdTime=Mon Jan 01 20:07:01 CST 2024, time=2024-01-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2193053, encodeId=c1192193053c9, content=请问一下。投稿三天后状态变成了Awaiting Second Opinion Awaiting AE Assignment 是什么意思呀，有知道的大佬吗？？？拜谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bdc65472221, createdName=ms3000001648120624, createdTime=Wed Mar 13 21:42:53 CST 2024, time=2024-03-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2152550, encodeId=d55a2152550b0, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：还没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09825505976, createdName=ms5000001091496643, createdTime=Sun Aug 13 12:00:10 CST 2023, time=2023-08-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1227649, encodeId=985e122e6492b, content=这个杂志有指定润色公司吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25515180429, createdName=146f649bm58(暂无昵称), createdTime=Tue Jun 21 00:03:40 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180288, encodeId=285c2180288d9, content=research checklist，大家提交了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Tue Jan 09 17:33:28 CST 2024, time=2024-01-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=495600, encodeId=fa88495600ad, content=排号一万多，Awaiting Reviewer Selection两个月，写了询问信，结果一天后reject!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=514, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed May 08 15:27:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2162635, encodeId=7e1a216263516, content=投稿命中率:75.0 偏重的研究方向：影像;临床医学 经验分享：我觉得总体来说很友好的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9f9f5496228, createdName=ms4000000755205675, createdTime=Fri Oct 13 20:07:53 CST 2023, time=2023-10-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=517588, encodeId=076d51e5883b, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：有幸成为今年的几篇中国文章之一，原以为这个杂志是教育方面的，经师兄推荐才知道什么医学科目都可以投，只要作者还是学生或低年资医生就可以。 审稿时间还行，一个月多一点，小修再小修后接收，15天就在线发表了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=95ec1668172, createdName=面膜大侠, createdTime=Mon Dec 14 12:11:00 CST 2015, time=2015-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198095, encodeId=2979219809508, content=偏重的研究方向：临床医学;Tumor 经验分享：我今天也投稿了这个杂志，期待！！与大家一起交流学习，这个杂志影响因子是5分的不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40612215025, createdName=120e3267m32暂无昵称, createdTime=Fri Apr 12 08:08:47 CST 2024, time=2024-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096940, encodeId=2391109694019, content=讨论一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2024-01-01 154528445 来自广东省

审稿速度:6.0 | 投稿命中率:75.0
偏重的研究方向：消化;内镜
经验分享：2023年9月投稿，一直在等待分配审稿人，11月收到邮件要求作者推荐审稿人，回复邮件后1个月状态变成了Awaiting reviewer，过了1-2周后状态变成Awaiting AE recommendation，又过了几天变成Awaiting EIC decision，等了1天，2024-01-01直接接收，审稿人提了几个意见，但没要求修改

93 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=2178642, encodeId=f00221e864287, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：消化;内镜 经验分享：2023年9月投稿，一直在等待分配审稿人，11月收到邮件要求作者推荐审稿人，回复邮件后1个月状态变成了Awaiting reviewer，过了1-2周后状态变成Awaiting AE recommendation，又过了几天变成Awaiting EIC decision，等了1天，2024-01-01直接接收，审稿人提了几个意见，但没要求修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4572634636, createdName=154528445, createdTime=Mon Jan 01 20:07:01 CST 2024, time=2024-01-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2193053, encodeId=c1192193053c9, content=请问一下。投稿三天后状态变成了Awaiting Second Opinion Awaiting AE Assignment 是什么意思呀，有知道的大佬吗？？？拜谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bdc65472221, createdName=ms3000001648120624, createdTime=Wed Mar 13 21:42:53 CST 2024, time=2024-03-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2152550, encodeId=d55a2152550b0, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：还没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09825505976, createdName=ms5000001091496643, createdTime=Sun Aug 13 12:00:10 CST 2023, time=2023-08-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1227649, encodeId=985e122e6492b, content=这个杂志有指定润色公司吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25515180429, createdName=146f649bm58(暂无昵称), createdTime=Tue Jun 21 00:03:40 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180288, encodeId=285c2180288d9, content=research checklist，大家提交了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Tue Jan 09 17:33:28 CST 2024, time=2024-01-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=495600, encodeId=fa88495600ad, content=排号一万多，Awaiting Reviewer Selection两个月，写了询问信，结果一天后reject!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=514, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed May 08 15:27:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2162635, encodeId=7e1a216263516, content=投稿命中率:75.0 偏重的研究方向：影像;临床医学 经验分享：我觉得总体来说很友好的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9f9f5496228, createdName=ms4000000755205675, createdTime=Fri Oct 13 20:07:53 CST 2023, time=2023-10-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=517588, encodeId=076d51e5883b, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：有幸成为今年的几篇中国文章之一，原以为这个杂志是教育方面的，经师兄推荐才知道什么医学科目都可以投，只要作者还是学生或低年资医生就可以。 审稿时间还行，一个月多一点，小修再小修后接收，15天就在线发表了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=95ec1668172, createdName=面膜大侠, createdTime=Mon Dec 14 12:11:00 CST 2015, time=2015-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198095, encodeId=2979219809508, content=偏重的研究方向：临床医学;Tumor 经验分享：我今天也投稿了这个杂志，期待！！与大家一起交流学习，这个杂志影响因子是5分的不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40612215025, createdName=120e3267m32暂无昵称, createdTime=Fri Apr 12 08:08:47 CST 2024, time=2024-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096940, encodeId=2391109694019, content=讨论一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2024-03-13 ms3000001648120624 来自上海

请问一下。投稿三天后状态变成了Awaiting Second Opinion Awaiting AE Assignment 是什么意思呀，有知道的大佬吗？？？拜谢！

91 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2178642, encodeId=f00221e864287, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：消化;内镜 经验分享：2023年9月投稿，一直在等待分配审稿人，11月收到邮件要求作者推荐审稿人，回复邮件后1个月状态变成了Awaiting reviewer，过了1-2周后状态变成Awaiting AE recommendation，又过了几天变成Awaiting EIC decision，等了1天，2024-01-01直接接收，审稿人提了几个意见，但没要求修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4572634636, createdName=154528445, createdTime=Mon Jan 01 20:07:01 CST 2024, time=2024-01-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2193053, encodeId=c1192193053c9, content=请问一下。投稿三天后状态变成了Awaiting Second Opinion Awaiting AE Assignment 是什么意思呀，有知道的大佬吗？？？拜谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bdc65472221, createdName=ms3000001648120624, createdTime=Wed Mar 13 21:42:53 CST 2024, time=2024-03-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2152550, encodeId=d55a2152550b0, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：还没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09825505976, createdName=ms5000001091496643, createdTime=Sun Aug 13 12:00:10 CST 2023, time=2023-08-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1227649, encodeId=985e122e6492b, content=这个杂志有指定润色公司吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25515180429, createdName=146f649bm58(暂无昵称), createdTime=Tue Jun 21 00:03:40 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180288, encodeId=285c2180288d9, content=research checklist，大家提交了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Tue Jan 09 17:33:28 CST 2024, time=2024-01-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=495600, encodeId=fa88495600ad, content=排号一万多，Awaiting Reviewer Selection两个月，写了询问信，结果一天后reject!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=514, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed May 08 15:27:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2162635, encodeId=7e1a216263516, content=投稿命中率:75.0 偏重的研究方向：影像;临床医学 经验分享：我觉得总体来说很友好的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9f9f5496228, createdName=ms4000000755205675, createdTime=Fri Oct 13 20:07:53 CST 2023, time=2023-10-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=517588, encodeId=076d51e5883b, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：有幸成为今年的几篇中国文章之一，原以为这个杂志是教育方面的，经师兄推荐才知道什么医学科目都可以投，只要作者还是学生或低年资医生就可以。 审稿时间还行，一个月多一点，小修再小修后接收，15天就在线发表了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=95ec1668172, createdName=面膜大侠, createdTime=Mon Dec 14 12:11:00 CST 2015, time=2015-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198095, encodeId=2979219809508, content=偏重的研究方向：临床医学;Tumor 经验分享：我今天也投稿了这个杂志，期待！！与大家一起交流学习，这个杂志影响因子是5分的不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40612215025, createdName=120e3267m32暂无昵称, createdTime=Fri Apr 12 08:08:47 CST 2024, time=2024-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096940, encodeId=2391109694019, content=讨论一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2023-08-13 ms5000001091496643 来自浙江省

审稿速度:1.0 | 投稿命中率:95.0
经验分享：还没投

104 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2178642, encodeId=f00221e864287, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：消化;内镜 经验分享：2023年9月投稿，一直在等待分配审稿人，11月收到邮件要求作者推荐审稿人，回复邮件后1个月状态变成了Awaiting reviewer，过了1-2周后状态变成Awaiting AE recommendation，又过了几天变成Awaiting EIC decision，等了1天，2024-01-01直接接收，审稿人提了几个意见，但没要求修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4572634636, createdName=154528445, createdTime=Mon Jan 01 20:07:01 CST 2024, time=2024-01-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2193053, encodeId=c1192193053c9, content=请问一下。投稿三天后状态变成了Awaiting Second Opinion Awaiting AE Assignment 是什么意思呀，有知道的大佬吗？？？拜谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bdc65472221, createdName=ms3000001648120624, createdTime=Wed Mar 13 21:42:53 CST 2024, time=2024-03-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2152550, encodeId=d55a2152550b0, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：还没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09825505976, createdName=ms5000001091496643, createdTime=Sun Aug 13 12:00:10 CST 2023, time=2023-08-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1227649, encodeId=985e122e6492b, content=这个杂志有指定润色公司吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25515180429, createdName=146f649bm58(暂无昵称), createdTime=Tue Jun 21 00:03:40 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180288, encodeId=285c2180288d9, content=research checklist，大家提交了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Tue Jan 09 17:33:28 CST 2024, time=2024-01-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=495600, encodeId=fa88495600ad, content=排号一万多，Awaiting Reviewer Selection两个月，写了询问信，结果一天后reject!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=514, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed May 08 15:27:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2162635, encodeId=7e1a216263516, content=投稿命中率:75.0 偏重的研究方向：影像;临床医学 经验分享：我觉得总体来说很友好的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9f9f5496228, createdName=ms4000000755205675, createdTime=Fri Oct 13 20:07:53 CST 2023, time=2023-10-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=517588, encodeId=076d51e5883b, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：有幸成为今年的几篇中国文章之一，原以为这个杂志是教育方面的，经师兄推荐才知道什么医学科目都可以投，只要作者还是学生或低年资医生就可以。 审稿时间还行，一个月多一点，小修再小修后接收，15天就在线发表了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=95ec1668172, createdName=面膜大侠, createdTime=Mon Dec 14 12:11:00 CST 2015, time=2015-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198095, encodeId=2979219809508, content=偏重的研究方向：临床医学;Tumor 经验分享：我今天也投稿了这个杂志，期待！！与大家一起交流学习，这个杂志影响因子是5分的不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40612215025, createdName=120e3267m32暂无昵称, createdTime=Fri Apr 12 08:08:47 CST 2024, time=2024-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096940, encodeId=2391109694019, content=讨论一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2022-06-21 146f649bm58(暂无昵称)

这个杂志有指定润色公司吗

58 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2178642, encodeId=f00221e864287, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：消化;内镜 经验分享：2023年9月投稿，一直在等待分配审稿人，11月收到邮件要求作者推荐审稿人，回复邮件后1个月状态变成了Awaiting reviewer，过了1-2周后状态变成Awaiting AE recommendation，又过了几天变成Awaiting EIC decision，等了1天，2024-01-01直接接收，审稿人提了几个意见，但没要求修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4572634636, createdName=154528445, createdTime=Mon Jan 01 20:07:01 CST 2024, time=2024-01-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2193053, encodeId=c1192193053c9, content=请问一下。投稿三天后状态变成了Awaiting Second Opinion Awaiting AE Assignment 是什么意思呀，有知道的大佬吗？？？拜谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bdc65472221, createdName=ms3000001648120624, createdTime=Wed Mar 13 21:42:53 CST 2024, time=2024-03-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2152550, encodeId=d55a2152550b0, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：还没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09825505976, createdName=ms5000001091496643, createdTime=Sun Aug 13 12:00:10 CST 2023, time=2023-08-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1227649, encodeId=985e122e6492b, content=这个杂志有指定润色公司吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25515180429, createdName=146f649bm58(暂无昵称), createdTime=Tue Jun 21 00:03:40 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180288, encodeId=285c2180288d9, content=research checklist，大家提交了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Tue Jan 09 17:33:28 CST 2024, time=2024-01-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=495600, encodeId=fa88495600ad, content=排号一万多，Awaiting Reviewer Selection两个月，写了询问信，结果一天后reject!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=514, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed May 08 15:27:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2162635, encodeId=7e1a216263516, content=投稿命中率:75.0 偏重的研究方向：影像;临床医学 经验分享：我觉得总体来说很友好的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9f9f5496228, createdName=ms4000000755205675, createdTime=Fri Oct 13 20:07:53 CST 2023, time=2023-10-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=517588, encodeId=076d51e5883b, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：有幸成为今年的几篇中国文章之一，原以为这个杂志是教育方面的，经师兄推荐才知道什么医学科目都可以投，只要作者还是学生或低年资医生就可以。 审稿时间还行，一个月多一点，小修再小修后接收，15天就在线发表了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=95ec1668172, createdName=面膜大侠, createdTime=Mon Dec 14 12:11:00 CST 2015, time=2015-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198095, encodeId=2979219809508, content=偏重的研究方向：临床医学;Tumor 经验分享：我今天也投稿了这个杂志，期待！！与大家一起交流学习，这个杂志影响因子是5分的不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40612215025, createdName=120e3267m32暂无昵称, createdTime=Fri Apr 12 08:08:47 CST 2024, time=2024-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096940, encodeId=2391109694019, content=讨论一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2024-01-09 国统乃我辈之愿来自广东省

research checklist，大家提交了吗

97 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2178642, encodeId=f00221e864287, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：消化;内镜 经验分享：2023年9月投稿，一直在等待分配审稿人，11月收到邮件要求作者推荐审稿人，回复邮件后1个月状态变成了Awaiting reviewer，过了1-2周后状态变成Awaiting AE recommendation，又过了几天变成Awaiting EIC decision，等了1天，2024-01-01直接接收，审稿人提了几个意见，但没要求修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4572634636, createdName=154528445, createdTime=Mon Jan 01 20:07:01 CST 2024, time=2024-01-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2193053, encodeId=c1192193053c9, content=请问一下。投稿三天后状态变成了Awaiting Second Opinion Awaiting AE Assignment 是什么意思呀，有知道的大佬吗？？？拜谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bdc65472221, createdName=ms3000001648120624, createdTime=Wed Mar 13 21:42:53 CST 2024, time=2024-03-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2152550, encodeId=d55a2152550b0, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：还没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09825505976, createdName=ms5000001091496643, createdTime=Sun Aug 13 12:00:10 CST 2023, time=2023-08-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1227649, encodeId=985e122e6492b, content=这个杂志有指定润色公司吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25515180429, createdName=146f649bm58(暂无昵称), createdTime=Tue Jun 21 00:03:40 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180288, encodeId=285c2180288d9, content=research checklist，大家提交了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Tue Jan 09 17:33:28 CST 2024, time=2024-01-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=495600, encodeId=fa88495600ad, content=排号一万多，Awaiting Reviewer Selection两个月，写了询问信，结果一天后reject!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=514, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed May 08 15:27:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2162635, encodeId=7e1a216263516, content=投稿命中率:75.0 偏重的研究方向：影像;临床医学 经验分享：我觉得总体来说很友好的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9f9f5496228, createdName=ms4000000755205675, createdTime=Fri Oct 13 20:07:53 CST 2023, time=2023-10-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=517588, encodeId=076d51e5883b, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：有幸成为今年的几篇中国文章之一，原以为这个杂志是教育方面的，经师兄推荐才知道什么医学科目都可以投，只要作者还是学生或低年资医生就可以。 审稿时间还行，一个月多一点，小修再小修后接收，15天就在线发表了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=95ec1668172, createdName=面膜大侠, createdTime=Mon Dec 14 12:11:00 CST 2015, time=2015-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198095, encodeId=2979219809508, content=偏重的研究方向：临床医学;Tumor 经验分享：我今天也投稿了这个杂志，期待！！与大家一起交流学习，这个杂志影响因子是5分的不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40612215025, createdName=120e3267m32暂无昵称, createdTime=Fri Apr 12 08:08:47 CST 2024, time=2024-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096940, encodeId=2391109694019, content=讨论一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2013-05-08 匿名用户

排号一万多，Awaiting Reviewer Selection两个月，写了询问信，结果一天后reject!

514 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2178642, encodeId=f00221e864287, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：消化;内镜 经验分享：2023年9月投稿，一直在等待分配审稿人，11月收到邮件要求作者推荐审稿人，回复邮件后1个月状态变成了Awaiting reviewer，过了1-2周后状态变成Awaiting AE recommendation，又过了几天变成Awaiting EIC decision，等了1天，2024-01-01直接接收，审稿人提了几个意见，但没要求修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4572634636, createdName=154528445, createdTime=Mon Jan 01 20:07:01 CST 2024, time=2024-01-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2193053, encodeId=c1192193053c9, content=请问一下。投稿三天后状态变成了Awaiting Second Opinion Awaiting AE Assignment 是什么意思呀，有知道的大佬吗？？？拜谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bdc65472221, createdName=ms3000001648120624, createdTime=Wed Mar 13 21:42:53 CST 2024, time=2024-03-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2152550, encodeId=d55a2152550b0, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：还没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09825505976, createdName=ms5000001091496643, createdTime=Sun Aug 13 12:00:10 CST 2023, time=2023-08-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1227649, encodeId=985e122e6492b, content=这个杂志有指定润色公司吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25515180429, createdName=146f649bm58(暂无昵称), createdTime=Tue Jun 21 00:03:40 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180288, encodeId=285c2180288d9, content=research checklist，大家提交了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Tue Jan 09 17:33:28 CST 2024, time=2024-01-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=495600, encodeId=fa88495600ad, content=排号一万多，Awaiting Reviewer Selection两个月，写了询问信，结果一天后reject!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=514, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed May 08 15:27:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2162635, encodeId=7e1a216263516, content=投稿命中率:75.0 偏重的研究方向：影像;临床医学 经验分享：我觉得总体来说很友好的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9f9f5496228, createdName=ms4000000755205675, createdTime=Fri Oct 13 20:07:53 CST 2023, time=2023-10-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=517588, encodeId=076d51e5883b, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：有幸成为今年的几篇中国文章之一，原以为这个杂志是教育方面的，经师兄推荐才知道什么医学科目都可以投，只要作者还是学生或低年资医生就可以。 审稿时间还行，一个月多一点，小修再小修后接收，15天就在线发表了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=95ec1668172, createdName=面膜大侠, createdTime=Mon Dec 14 12:11:00 CST 2015, time=2015-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198095, encodeId=2979219809508, content=偏重的研究方向：临床医学;Tumor 经验分享：我今天也投稿了这个杂志，期待！！与大家一起交流学习，这个杂志影响因子是5分的不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40612215025, createdName=120e3267m32暂无昵称, createdTime=Fri Apr 12 08:08:47 CST 2024, time=2024-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096940, encodeId=2391109694019, content=讨论一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2023-10-13 ms4000000755205675 来自浙江省

投稿命中率:75.0
偏重的研究方向：影像;临床医学
经验分享：我觉得总体来说很友好的杂志

99 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2178642, encodeId=f00221e864287, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：消化;内镜 经验分享：2023年9月投稿，一直在等待分配审稿人，11月收到邮件要求作者推荐审稿人，回复邮件后1个月状态变成了Awaiting reviewer，过了1-2周后状态变成Awaiting AE recommendation，又过了几天变成Awaiting EIC decision，等了1天，2024-01-01直接接收，审稿人提了几个意见，但没要求修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4572634636, createdName=154528445, createdTime=Mon Jan 01 20:07:01 CST 2024, time=2024-01-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2193053, encodeId=c1192193053c9, content=请问一下。投稿三天后状态变成了Awaiting Second Opinion Awaiting AE Assignment 是什么意思呀，有知道的大佬吗？？？拜谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bdc65472221, createdName=ms3000001648120624, createdTime=Wed Mar 13 21:42:53 CST 2024, time=2024-03-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2152550, encodeId=d55a2152550b0, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：还没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09825505976, createdName=ms5000001091496643, createdTime=Sun Aug 13 12:00:10 CST 2023, time=2023-08-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1227649, encodeId=985e122e6492b, content=这个杂志有指定润色公司吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25515180429, createdName=146f649bm58(暂无昵称), createdTime=Tue Jun 21 00:03:40 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180288, encodeId=285c2180288d9, content=research checklist，大家提交了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Tue Jan 09 17:33:28 CST 2024, time=2024-01-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=495600, encodeId=fa88495600ad, content=排号一万多，Awaiting Reviewer Selection两个月，写了询问信，结果一天后reject!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=514, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed May 08 15:27:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2162635, encodeId=7e1a216263516, content=投稿命中率:75.0 偏重的研究方向：影像;临床医学 经验分享：我觉得总体来说很友好的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9f9f5496228, createdName=ms4000000755205675, createdTime=Fri Oct 13 20:07:53 CST 2023, time=2023-10-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=517588, encodeId=076d51e5883b, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：有幸成为今年的几篇中国文章之一，原以为这个杂志是教育方面的，经师兄推荐才知道什么医学科目都可以投，只要作者还是学生或低年资医生就可以。 审稿时间还行，一个月多一点，小修再小修后接收，15天就在线发表了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=95ec1668172, createdName=面膜大侠, createdTime=Mon Dec 14 12:11:00 CST 2015, time=2015-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198095, encodeId=2979219809508, content=偏重的研究方向：临床医学;Tumor 经验分享：我今天也投稿了这个杂志，期待！！与大家一起交流学习，这个杂志影响因子是5分的不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40612215025, createdName=120e3267m32暂无昵称, createdTime=Fri Apr 12 08:08:47 CST 2024, time=2024-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096940, encodeId=2391109694019, content=讨论一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2015-12-14 面膜大侠

审稿速度:2.0 | 投稿命中率:50.0
经验分享：有幸成为今年的几篇中国文章之一，原以为这个杂志是教育方面的，经师兄推荐才知道什么医学科目都可以投，只要作者还是学生或低年资医生就可以。
审稿时间还行，一个月多一点，小修再小修后接收，15天就在线发表了

435 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2178642, encodeId=f00221e864287, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：消化;内镜 经验分享：2023年9月投稿，一直在等待分配审稿人，11月收到邮件要求作者推荐审稿人，回复邮件后1个月状态变成了Awaiting reviewer，过了1-2周后状态变成Awaiting AE recommendation，又过了几天变成Awaiting EIC decision，等了1天，2024-01-01直接接收，审稿人提了几个意见，但没要求修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4572634636, createdName=154528445, createdTime=Mon Jan 01 20:07:01 CST 2024, time=2024-01-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2193053, encodeId=c1192193053c9, content=请问一下。投稿三天后状态变成了Awaiting Second Opinion Awaiting AE Assignment 是什么意思呀，有知道的大佬吗？？？拜谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bdc65472221, createdName=ms3000001648120624, createdTime=Wed Mar 13 21:42:53 CST 2024, time=2024-03-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2152550, encodeId=d55a2152550b0, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：还没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09825505976, createdName=ms5000001091496643, createdTime=Sun Aug 13 12:00:10 CST 2023, time=2023-08-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1227649, encodeId=985e122e6492b, content=这个杂志有指定润色公司吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25515180429, createdName=146f649bm58(暂无昵称), createdTime=Tue Jun 21 00:03:40 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180288, encodeId=285c2180288d9, content=research checklist，大家提交了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Tue Jan 09 17:33:28 CST 2024, time=2024-01-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=495600, encodeId=fa88495600ad, content=排号一万多，Awaiting Reviewer Selection两个月，写了询问信，结果一天后reject!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=514, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed May 08 15:27:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2162635, encodeId=7e1a216263516, content=投稿命中率:75.0 偏重的研究方向：影像;临床医学 经验分享：我觉得总体来说很友好的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9f9f5496228, createdName=ms4000000755205675, createdTime=Fri Oct 13 20:07:53 CST 2023, time=2023-10-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=517588, encodeId=076d51e5883b, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：有幸成为今年的几篇中国文章之一，原以为这个杂志是教育方面的，经师兄推荐才知道什么医学科目都可以投，只要作者还是学生或低年资医生就可以。 审稿时间还行，一个月多一点，小修再小修后接收，15天就在线发表了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=95ec1668172, createdName=面膜大侠, createdTime=Mon Dec 14 12:11:00 CST 2015, time=2015-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198095, encodeId=2979219809508, content=偏重的研究方向：临床医学;Tumor 经验分享：我今天也投稿了这个杂志，期待！！与大家一起交流学习，这个杂志影响因子是5分的不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40612215025, createdName=120e3267m32暂无昵称, createdTime=Fri Apr 12 08:08:47 CST 2024, time=2024-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096940, encodeId=2391109694019, content=讨论一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2024-04-12 120e3267m32暂无昵称

偏重的研究方向：临床医学;Tumor
经验分享：我今天也投稿了这个杂志，期待！！与大家一起交流学习，这个杂志影响因子是5分的不？

1 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2178642, encodeId=f00221e864287, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：消化;内镜 经验分享：2023年9月投稿，一直在等待分配审稿人，11月收到邮件要求作者推荐审稿人，回复邮件后1个月状态变成了Awaiting reviewer，过了1-2周后状态变成Awaiting AE recommendation，又过了几天变成Awaiting EIC decision，等了1天，2024-01-01直接接收，审稿人提了几个意见，但没要求修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4572634636, createdName=154528445, createdTime=Mon Jan 01 20:07:01 CST 2024, time=2024-01-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2193053, encodeId=c1192193053c9, content=请问一下。投稿三天后状态变成了Awaiting Second Opinion Awaiting AE Assignment 是什么意思呀，有知道的大佬吗？？？拜谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bdc65472221, createdName=ms3000001648120624, createdTime=Wed Mar 13 21:42:53 CST 2024, time=2024-03-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2152550, encodeId=d55a2152550b0, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：还没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09825505976, createdName=ms5000001091496643, createdTime=Sun Aug 13 12:00:10 CST 2023, time=2023-08-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1227649, encodeId=985e122e6492b, content=这个杂志有指定润色公司吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25515180429, createdName=146f649bm58(暂无昵称), createdTime=Tue Jun 21 00:03:40 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180288, encodeId=285c2180288d9, content=research checklist，大家提交了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Tue Jan 09 17:33:28 CST 2024, time=2024-01-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=495600, encodeId=fa88495600ad, content=排号一万多，Awaiting Reviewer Selection两个月，写了询问信，结果一天后reject!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=514, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed May 08 15:27:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2162635, encodeId=7e1a216263516, content=投稿命中率:75.0 偏重的研究方向：影像;临床医学 经验分享：我觉得总体来说很友好的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9f9f5496228, createdName=ms4000000755205675, createdTime=Fri Oct 13 20:07:53 CST 2023, time=2023-10-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=517588, encodeId=076d51e5883b, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：有幸成为今年的几篇中国文章之一，原以为这个杂志是教育方面的，经师兄推荐才知道什么医学科目都可以投，只要作者还是学生或低年资医生就可以。 审稿时间还行，一个月多一点，小修再小修后接收，15天就在线发表了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=95ec1668172, createdName=面膜大侠, createdTime=Mon Dec 14 12:11:00 CST 2015, time=2015-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198095, encodeId=2979219809508, content=偏重的研究方向：临床医学;Tumor 经验分享：我今天也投稿了这个杂志，期待！！与大家一起交流学习，这个杂志影响因子是5分的不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40612215025, createdName=120e3267m32暂无昵称, createdTime=Fri Apr 12 08:08:47 CST 2024, time=2024-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096940, encodeId=2391109694019, content=讨论一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2021-12-28 衣谷

讨论一般分几段？

0 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务